Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
979
datasets available to search
ShareScore release 0.9.0
Dataset results
979 results for “HR”
Screening Test Accuracy of Gynocular™, HR-HPV Testing, VIA for Detection of Cervical Neoplastic Lesions, in Women Living With HIV
ClinicalTrials.gov study NCT03931083. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
HR-lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease
ClinicalTrials.gov study NCT01365286. IPD Sharing: Not stated. Countries: 1. Publications: 36.
A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov study NCT05433480. IPD Sharing: NO. Countries: 1. Publications: 2.
Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT03555877. IPD Sharing: NO. Countries: 1. Publications: 2.
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer
ClinicalTrials.gov study NCT03820830. IPD Sharing: NO. Countries: 6. Publications: 9.
A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer
ClinicalTrials.gov study NCT06341283. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive（HR+） Metastatic Breast Cancer(MBC) .
ClinicalTrials.gov study NCT06734533. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
ClinicalTrials.gov study NCT03711032. IPD Sharing: YES. Countries: 29. Publications: 1.
Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer
ClinicalTrials.gov study NCT04851613. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Exploration of Dalpiciclib + Chidamide in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor: a Phase Ⅰb Study
ClinicalTrials.gov study NCT05586841. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant
ClinicalTrials.gov study NCT04899349. IPD Sharing: YES. Countries: 2. Publications: 0.
Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)
ClinicalTrials.gov study NCT02802748. IPD Sharing: NO. Countries: 1. Publications: 1.
Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer
ClinicalTrials.gov study NCT06201234. IPD Sharing: YES. Countries: 1. Publications: 4.
Prospective Observation for Serial Changes in Acute Intracranial Artery Dissection Using HR-MRI
ClinicalTrials.gov study NCT03213470. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study
ClinicalTrials.gov study NCT04334993. IPD Sharing: NO. Countries: 1. Publications: 0.
Does Hr-HPV Status Influence the 2011 IFCPC Nomenclature and Swede Score's Capacity to Diagnose Precancerous Lesions?
ClinicalTrials.gov study NCT07012356. IPD Sharing: NO. Countries: 1. Publications: 13.
Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients
ClinicalTrials.gov study NCT02294539. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC
ClinicalTrials.gov study NCT04055493. IPD Sharing: YES. Countries: 1. Publications: 1.
TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.
ClinicalTrials.gov study NCT04498481. IPD Sharing: NO. Countries: 1. Publications: 1.
Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive，HR-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT04034589. IPD Sharing: NO. Countries: 1. Publications: 7.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.